|
|
|
|
Neurologic deterioration and DRESS occurred as several adverse drug effects of daclizumab treatment. Early diagnosis and treatment of DRESS are essential because it is associated with complications such as new autoimmune diseases and liver failure, and may even be lethal. Because of its potential serious side effects, daclizaumab was recently suspended for use in the European Union. |
|